pityriasis rosea after covid vaccine
Dodane 10 maja 2023Please enable it to take advantage of the complete set of features! Pityriasis rosea is a common self-limiting rash that usually starts with a herald patch on the trunk and progresses along the Langer lines to a generalized rash over the trunk and limbs. Abstract Dear Editor, Pityriasis rosea (PR) is a common, self-limited erythematous papulosquamous dermatosis that mainly affects young adults. -, Johansen M, Chisolm SS, Aspey LD, Brahmbhatt M. Pityriasis rosea in otherwise asymptomatic confirmed COVID-19-positive patients: a report of 2 cases. Results were typical for PR. Pityriasis rosea developing after COVID-19 vaccination. doi: 10.1111/jdv.12942, 13. Pityriasis rosea is a type of skin rash. Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination. Figure 1. Adya KA, Inamadar AC, Albadri W. Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male. Federal government websites often end in .gov or .mil. Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: A systematic review. MeSH See this image and copyright information in PMC. Gianotti-Crosti Syndrome is a rare skin disease affecting children at the first years of age. (A) Dermoscopic features: dotted and linear vessels forming a network on a yellowish background with some whitish peripheral scales (original magnification x20). Environ Sci Pollut Res. Cebeci Kahraman F, Sava Erdoan S, Akta ND, Albayrak H, Trkmen D, Borlu M, Arca DA, Demirba A, Akbayrak A, Polat Ekinci A, Gkek GE, elik HA, Taolar MK, An , Temiz SA, Hazinedar E, Ayhan E, Hzl P, Solak E, Kl A, Ylmaz E. J Cosmet Dermatol. (2015) 2015:253154. doi: 10.1155/2015/253154, 14. Disclaimer. doi: 10.1016/j.jaad.20.2103.092. The .gov means its official. We present a case of a pityriasis rosea-like rash occurring after Pfizer COVID-19 vaccination and review cases of pityriasis rosea (PR)/PR-like eruption (PR-LE) after mRNA COVID-19 vaccine published in the medical literature. Clin Dermatol. Wien Med Wochenschr. Involvement of the oral mucosa has also been reported in as many as 50% of all cases (11). 2021;185(2):e34. It was found popularly in the trunk area, either asymptomatically or with mild symptoms. pityriasis rosea after covid vaccine Last month at Barret-jackson in Scottsdale, Arizona a 1929 Roadster was put up for sale by Dave Kindig of . Conclusion: 2021 Jul;85(1):46-55. doi: 10.1016/j.jaad.2021.03.092. Histopathologic features: (B) microscopic image at a low power field showing psoriasiform epidermal hyperplasia, perivascular infiltration, and interface dermatitis (hematoxylin-eosin; scale bar represents 100 m); (C) microscopic image at a high power field showing focal spongiotic dermatitis, interface dermatitis, and perivascular infiltration of lymphocytes and eosinophils (hematoxylin-eosin; scale bar represents 40 m). The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unfortunately, due to her deteriorating neurologic status, her associated symptoms were not evaluated properly. Cureus. Drago F, Ciccarese G, Parodi A. Pityriasis rosea and pityriasis rosea-like eruptions: How to distinguish them? National Library of Medicine Unauthorized use of these marks is strictly prohibited. Factors affecting the severity of central centrifugal cicatricial alopecia. Table 1 summarizes all reported cases of PR-like eruption following COVID-19 vaccination. 2022;S0738-081X(22)00002-5. Busto-Leis JM, Servera-Negre G, Mayor-Ibarguren A, et al.. Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance, Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report, Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine. 8600 Rockville Pike official website and that any information you provide is encrypted J Med Virol. Figure 2. Welsh E, Cardenas-de la Garza JA, Cuellar-Barboza A, et al. However, pityriasis rosea is a selflimiting benign exanthema and does not require . -, Broccolo F., Drago F., Careddu A.M., et al. 2021 Dec;108(6):317-318. doi: 10.12788/cutis.0411. eCollection 2022. Before Accessibility There is a growing number of published cases that link PR to COVID-19 infection, with PR appearing either in the acute phase of COVID-19 or, as in our patient, in the post COVID-19 period (4-9). New urticaria in the weeks after COVID-19 vaccination (March 2023) OTHER DERMATOLOGY. The site is secure. official website and that any information you provide is encrypted The latter is found in a younger age group. In a Spanish study,PR/PRLE was observed in 11 patients (6.7%) vaccinated with BNT162b2, in 5 patients (3.4%) vaccinated with mRNA- 1273 and in 4 patients (4.2%) vaccinated with AZD1222.2 Available data suggest that BNT162b2 vaccine is more related to PR/PRLE than other vaccines. Meantime the onset, was 8.58 days, and meantime it took to recover, was 6.44 weeks. Sprinkle bath water with an oatmeal-based bath product (Aveeno). Many Americans become infected with them at an early age. doi: 10.1111/jdv.17316. Please enable it to take advantage of the complete set of features! Conclusions: We report a spectrum of cutaneous reactions after mRNA COVID-19 vaccines. Dear Editor, Pityriasis rosea (PR) is a common, self-limited erythematous papulosquamous dermatosis that mainly affects young adults. SPSS statistical software version 25 was used for appropriate inferential statistics. Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine. doi: 10.12998/wjcc.v5.i6.203, 6. The site is secure. An official website of the United States government. The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). 2022 by the American Academy of Dermatology, Inc. Pityriasis rosea (PR) is an acute exanthematous disease. Dermatol Reports. government site. All patients are currently in good general health. Since you said you felt ill at the time getting the vaccine you had covid at the time. Pityriasis rosea (PR)-like eruption is a cutaneous complication associated with several medications and vaccinations. The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited. Efficacy and safety of COVID19 vaccines: a systematic review. Xing K, Tu XY, Liu M, et al. tions reported after vaccination include: injection site reactions, urticarial and morbilliform eruptions, per-nio/chilblains, reactions to cosmetic llers, herpes zoster, herpes simplex ares, and pityriasis rosea-like rashes [1]. Tommy came by Kindig-it Design while on vacation, and after a great meeting with Dave, he decided to trade the ocean for the mountains. 2021 Sep;35(9):e546-e548. 17% get a rash first and then get other symptoms later on as disease progresses. Pityriasis rosea and pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination: a report of five cases and review of the literature. Background: After introducing Covid-19 vaccines, a few side effects were reported, pityriasis rosea being one of them.Therefore, this study will systematically review its manifestation afteradministration.Methods: Databases were searched, covering a timeline from December 1, 2019 to February 28, 2022.Data were independently extracted and accessed for bias. +39.3465909404. Careers. Epub 2022 Jan 31. doi: 10.1002/iid3.804. Thirty-one studies were included for data extraction after screening following the eligibility criteria. A Yale-led study published in the journal Immunity in May offers a few theories on why some children develop MIS-C and others don't. Morphologic misclassication is possible. Globally, as of 7:26 pm CEST, 10 October 2022, there have been 618,521,620 confirmed cases of COVID-19, including 6,534,725 deaths, reported to the WHO. Int J Dermatol. Dermatol Ther. Typically preceded by a primary solitary herald patch followed by the onset of smaller scaly papulo-squamous lesions on the skin tension lines within days to weeks.1 Reactivation of herpes virus 6 and 7 has been incriminated as a . -. Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature. 2021 Dec;108(6):317-318. doi: 10.12788/cutis.0411. 2022 May;35(5):e15391. The four stages of pityriasis rosea are: Preliminary stage: You feel ill for a day or two. 2022 Sep;21(9):3692-3703. doi: 10.1111/jocd.15209. The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Patient n. 1. Histopathologic examination revealed epidermal focal spongiosis, interface dermatitis with necrotic keratinocytes, perivascular lymphocytic infiltration, and few eosinophilic infiltrations in the superficial dermis (Figures 3B,C). sharing sensitive information, make sure youre on a federal Bethesda, MD 20894, Web Policies It may or may not be itchy and usually lasts six to eight weeks before resolving on its own. Dermatol Online J. N Engl J Med 2020; 383:260315. 18. walker hayes daughter. COVID-19 vaccine hesitancy is a critical problem that hinders J Eur Acad Dermatol Venereol. In an American study, the average latency time was 13 days.7 In the previous cited Turkish-Egyptian study, the average latency time was 12.7 days.17 In 22 cases the eruption appeared 1-21 days after the second dose (average: 8.8 days); in 2 cases the eruption occurred both after the first and the second dose. official website and that any information you provide is encrypted Department of Pathophysiology and Transplantation, Universit degli Studi, Foundation IRCCS Ca Granda Ospedale Maggiore Policlinico, Via Pace 9, 20122 Milan, Italy. sharing sensitive information, make sure youre on a federal Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: Case report and brief literature review. J Formos Med Assoc. Although histopathologic characteristics of PR are also observed in PR-like lesions, the presence of dyskeratotic keratinocytes, interface dermatitis, and eosinophilic infiltration in the dermis may be more prominent in PR-like eruptions (11). doi: 10.1111/dth.13650, 7. Epub 2022 Jan 5. Mohta A, Mohta A, Ghiya BC, Mehta RD, Kumar V. Indian J Dermatol. Clin Dermatol. Epub 2022 Jun 13. FOIA 2022 Sep-Oct;40(5):586-590. doi: 10.1016/j.clindermatol.2022.01.002. Most people with psoriasis should follow the same CDC guidelines for booster shots as the general public, says the NPF. official website and that any information you provide is encrypted (a) Pityriasis rosea (chest, flank, and axilla); (b) pityriasis rosea (back). doi: 10.1111/dth.15040, 3. 10.1136/POSTGRADMEDJ-2020-138234 2021 Dec;108(6):317-318. doi: 10.12788/cutis.0411. Suchonwanit P, Rojhirunsakool S, Khunkhet S. A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia. Hum Vaccin Immunother. Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine. It manifests as oval-shaped, pink or red . It's easily mistaken for scalp psoriasis and vice versa. Although the exact pathogenesis of PR remains unknown, the endogenous systemic reactivation of HHV (i.e., type 6 and 7) in the skin has been implicated as a precipitating factor. 2021;184(6):11941195. The https:// ensures that you are connecting to the Akdas E, Ilter N, Ogut B, Erdem O. Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report. Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine Pityriasis rosea (PR) is an acute papulosquamous cutaneous disorder that classically presents with a herald patch rapidly followed by a widespread rash along skin cleavage lines. and transmitted securely. doi: 10.1111/jdv.17342, 5. 2021 Aug;35(8):e491-e493. 10.1007/S10354-021-00876-0 PMC Marcantonio-Santa Cruz OY, Vidal-Navarro A, Pesqu D, Gimnez-Arnau AM, Pujol RM, Martin-Ezquerra G. J Eur Acad Dermatol Venereol. Ciccarese G, Parodi A, Drago F. SARS-CoV-2 as possible inducer of viral reactivations. Federal government websites often end in .gov or .mil. The exanthem was self-limited in both patients over a period of a month. They suggested that the short time elapsed between vaccination and PR onset resembled that of delayed localized cutaneous reactions occurring shortly after the second vaccine dose. Treatment with topical 0.1% triamcinolone acetonide twice per day showed partial response after seven days. doi: 10.1111/dth.15601. However, in cases of atypical PR, it may present with erythema multiforme-like lesions and purpura (5). 2022 Jul 6;15(1):9503. doi: 10.4081/dr.2022.9503. Authors Jordan E Buckley 1 , Laura N Landis 2 , Ronald P Rapini 1 Affiliations The .gov means its official. The length of the rash is shorter in comparison with PR.19. However, after 14 days, she developed multiple discrete blanching erythematous oval patches and plaques on the lower abdomen, back, and bilateral upper thighs (Figures 1A,B). The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. PS conceptualized the case report and revised the manuscript. Dursun R, Temiz SA. . This table includes information on vaccines that have published phase 3 trial data in the peer reviewed literature and are provisionally approved by the Australian Government Therapeutic Goods Administration (TGA). Epub 2022 Feb 9. Cyrenne BM, Al-Mohammedi F, DeKoven JG, Alhusayen R. Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 vaccine, Cutaneous adverse reactions after m- RNA COVID-19 vaccine: early reports from Northeast Italy. and transmitted securely. Clipboard, Search History, and several other advanced features are temporarily unavailable. Clipboard, Search History, and several other advanced features are temporarily unavailable. 2022 Jun;7:164-168. doi: 10.1016/j.jdin.2022.01.009. Federal government websites often end in .gov or .mil. PR 12.7 days (mean) after the vaccination (19 patients after the 1. [Epub ahead of print]. Accessibility Seborrheic dermatitis is a skin condition that mainly affects the scalp, causing scaly patches of red skin and stubborn dandruff. It is important for physicians to be aware of this self-limited reaction so they can reassure and appropriately counsel patients that it is safe to receive subsequent vaccine doses despite the cutaneous eruption. Moles, psoriasis, hives, eczema, and recently associated Covid-19 coronavirus rashes are just a few of the more than 3,000 skin disorders known to dermatology. Pityriasis is linked mainly with herpesviruses 6 and 7; only a . 2021 Nov;34(6):e15129. The pathogenesis of this relationship is unknown. Future studies should investigate oral lesions in SARS-CoV-2-positive subjects and after COVID-19 vaccination in the pediatric population, taking into account viral variants and newly developed vaccines. 2021;172:6369. Please enable it to take advantage of the complete set of features! Then you may get smaller spots that sweep out from the middle of the body in a shape that looks like drooping pine-tree branches. 8600 Rockville Pike 10.7499/J.ISSN.1008-8830.2101133 Cutaneous reactions after COVID-19 vaccination in Turkey: A multicenter study. Limitations: Registry analysis does not measure incidence. -, Cyrenne BM, Al-Mohammedi F, DeKoven JG, Alhusayen R. Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 vaccine. In some cases, central hyperpigmentation was identified. PR is a common self-limited papulosquamous eruption typically presenting with a large solitary pink-colored patch or plaque (i.e., herald patch), followed by secondary eruptions of smaller erythematous patches or plaques with associated peripheral collarette scaling distributed along the cleavage lines of the trunk, forming a Christmas tree pattern (5). -. No HHV-6 and HHV-7 reactivation is detected. doi: 10.1016/j.jaad.2020.04.094, 8. 21% of people who have Covid develop a rash as their only symptom of infection. Disclaimer. Pityriasis rosea (PR) is an acute, exanthematous disease likely caused by human herpesvirus (HHV)-6 and/or HHV-7. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher. Herald patch of pityriasis rosea. Vaccine-Related Eruptions of Papules and Plaques Following COVID-19 Vaccination - A Case Series. Martora F, Battista T, Marasca C, Genco L, Fabbrocini G, Potestio L. Clin Cosmet Investig Dermatol. 2022 May;121(5):1003-1007. doi: 10.1016/j.jfma.2021.12.028. Would you like email updates of new search results? COVID19 MapJohns Hopkins Coronavirus Resource Center. Careers. Six weeks prior to the appearance of the initial skin lesion, the patient had coronavirus disease 2019 (COVID-19) infection with mild clinical presentation (fever up to 38 C lasting for four days and mild headache) and with symptoms of post COVID-19 syndrome (excessive tiredness). PR has also been reported to follow COVID-19 vaccination (11). Physicians should be aware that pityriasis rosea is a rare side-effect of COVID-19 vaccination.Pityriasis rosea is self-limiting and no medical treatment is usually required. 8600 Rockville Pike Moreover, almost all lesions faded with associated post-inflammatory hyperpigmentation (Figure 2B). Peripheral eosinophilia is often present. Accessibility HHS Vulnerability Disclosure, Help Umakanthan S, Sahu P, Ranade AV, et al. Pityriasis rosea (PR), PR-like eruptions (PR-LE), and herpes zoster have been frequently reported during the COVID-19 pandemic and following COVID-19 vaccination. Postgrad Med J. 2022 Aug;35(8):e15601. Numerous scattered erythematous plaques with fine scale oriented along skin cleavage, Herald patch of pityriasis rosea. PRISMA, preferred reporting. He described the appearance of an erythematous centrally scaled lesion at the right part of his abdomen, followed by the spreading of red oval mildly scaling lesions on the trunk, neck, and proximal parts of the upper extremities, which showed in the physical examination (Figure 1, a and b). National Library of Medicine doi: 10.1111/dth.13878, 10. 8600 Rockville Pike Cite this: Skin Reactions After COVID-19 Vaccination . The duration of the infection ranges from two weeks to three months. The following self-care tips may help relieve the discomfort of pityriasis rosea: Take nonprescription allergy medicine (antihistamines), such as diphenhydramine (Benadryl, others). The https:// ensures that you are connecting to the Pityriasis rosea (PR) is an acute papulosquamous cutaneous disorder that classically presents with a herald patch rapidly followed by a widespread rash along skin cleavage lines. Pityriasis rosea following SARS-CoV-2 vaccination: A case series. and transmitted securely. SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19. 2022 Jun;7:164-168. doi: 10.1016/j.jdin.2022.01.009. Pityriasis rosea and pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination: a report of five cases and review of the literature. Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: A systematic review. JAAD Case Rep. (2018) 4:8001. PMC Before Please enable it to take advantage of the complete set of features! These types cannot cause cold sores or genital herpes. -. Few brownish patches also appeared, suggestive of post-inflammatory hyperpigmentation. 2023 Apr;11(4):e804. Would you like email updates of new search results? Cutaneous Sarcoidosis-like Eruption Following Second Dose of Moderna mRNA-1273 Vaccine: Case or Relationship? 2022 Jul 6;15(1):9503. doi: 10.4081/dr.2022.9503. An official website of the United States government. COVID-19 has been reported as one such viral trigger for PR. This site needs JavaScript to work properly. Reactions related to the hair have so far not been reported. Br J Dermatol. The site is secure. Four patients were subjected to the second vaccination, but no skin lesions appeared. Accessibility However, several adverse effects of COVID-19 vaccination have been identified. Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature. Copyright 2021 Leerunyakul, Pakornphadungsit and Suchonwanit. The study is created by eHealthMe and uses data from the Food and Drug Administration (FDA). 2023 Apr;11(4):e804. This is called a herald patch and may be up to 4 inches (10 centimeters) across. Although the most severe manifestations concern the lower respiratory tract, COVID-19 is a multiorgan disease that also affects the skin. Due to the rising incidence of coronavirus disease 2019 (COVID-19) worldwide, mass vaccination has been the cornerstone in preventing viral spread and decreasing morbidity and mortality. In addition to reactivation of HHV-6 or HHV-7, PR can be triggered by some drugs (like angiotensin-converting enzyme inhibitors alone or in combination with hydrochlorothiazide, sartans plus hydrochlorothiazide, allopurinol, nimesulide, and acetyl salicylic acid (2) and vaccines (such as smallpox, poliomyelitis, influenza, human papillomavirus, diphtheria, tuberculosis, hepatitis B, pneumococcus, and yellow fever vaccines) (3). Due to the rising incidence of coronavirus disease 2019 (COVID-19) worldwide, mass vaccination has been the cornerstone in preventing viral spread and decreasing morbidity and mortality. Figure 3. Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine. PRISMA, preferred reporting items for systematic reviews and metaanalysis. NS, not specified; PR, pityriasis rosea; PRL, pityriasis rosea-like. Abdullah L, Hasbani D, Kurban M, Abbas O. Pityriasis rosea after mRNA COVID-19 vaccination, Two cases of pityriasis rosea after the injection of coronavirus disease 2019 vaccine, Erythema nodosum, zoster duplex and pityriasis rosea as possible cutaneous adverse effects of Oxford-AstraZeneca COVID-19 vaccine: report of three cases from India, Atypical pityriasis rosea associated with mRNA COVID- 19 vaccine, Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male, Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: case report and brief literature review. Alvin Friedman-Kien, MD, walked through the doorway into the exam room, looked at me and immediately said, "Oh, you have pityriasis rosea." He called in a bunch of residents so he could show them my rash and teach them about the condition, which often has a large patch called the "mother patch" (or herald patch), as well as smaller . HHS Vulnerability Disclosure, Help HHS Vulnerability Disclosure, Help Pityriasis rosea (PR)-like eruption is a rare cutaneous complication of immunization. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID19). Changes in color or texture can result from inflammation, infection, or allergic reactions anywhere on the body. The site is secure. J Eur Acad Dermatol Venereol. doi: 10.1159/000517971. Epub 2022 Jun 13. 2021 Sep;60(9):1150-1151. doi: 10.1111/ijd.15700. He denied oropharyngeal lesions. -, Rasheed R, Rizwan A, Javed H, Sharif F, Zaidi A. Socioeconomic and environmental impacts of COVID19 pandemic in Pakistanan integrated analysis. . doi: 10.1002/iid3.804. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). Epub 2021 Aug 26. An official website of the United States government. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. Keywords: Availability of data and material: Data and materials are available by the authors. Received: 03 August 2021; Accepted: 17 August 2021; Published: 07 September 2021. The .gov means its official. Spongiotic dermatitis was the most commonly reported cutaneous reaction to COVID-19 vaccination among patients who also had biopsy results available for review, according to a registry-based. Int J Dermatol. This site needs JavaScript to work properly. (2016) 55:e33843. Databases were searched, covering a timeline from December 1, 2019 to February 28, 2022. No use, distribution or reproduction is permitted which does not comply with these terms. Ehsani AH, Nasimi M, Bigdelo Z. Pityriasis rosea as a cutaneous manifestation of COVID-19 infection. Other plausible theories include molecular mimicry with viral epitopes and type IV delayed hypersensitivity reaction (12). doi: 10.1111/bjd.20143. Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male. The .gov means its official. Keywords: Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance. Tina Burke, 40, a nurse who works on the oncology floor at Massachusetts General Hospital (MGH), received her first coronavirus shot on Jan. 3. reactions included pernio/chilblains, cosmetic ller reactions, zoster, herpes simplex ares, and pityriasis rosea-like reactions. MeSH Here, we report the first case of PR-like eruption following ChAdOx1 nCoV-19 (Oxford/AstraZeneca) vaccination. A spectrum of cutaneous reactions to SARs-CoV-2 (COVID-19) vaccines have been reported in the literature. Central dusky-red erythematous on some plaques (A); almost all lesions fading with associated post-inflammatory hyperpigmentation after treatment (B). 1. FOIA J Eur Acad Dermatol Venereol. -, Wollina U, Chiriac A, Kocic H, Koch A, Brzezinski P. Cutaneous and hypersensitivity reactions associated with COVID19 vaccinationa narrative review. See All You will learn Airbrushing, Pinstriping, and Woodgrain. 2022 Jul 6;15(1):9503. doi: 10.4081/dr.2022.9503. Epub 2022 Jan 5. Epub 2022 Jan 31. Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine. In the period May 2021- February 2022 we observed five cases of clinically typical PR that appeared 2 to 3 weeks after anti-SARS-CoV-2 vaccination with BNT162b2 (3 patients) or mRNA- 1273 (2 patients). MeSH eCollection 2022. Abdullah L, Hasbani D, Kurban M, Abbas O. Pityriasis rosea after mRNA COVID-19 vaccination. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. J Formos Med Assoc. This site needs JavaScript to work properly. Martora F, Picone V, Battista T, Fabbrocini G, Marasca C. Dermatol Ther. Unable to load your collection due to an error, Unable to load your delegates due to an error. As with eczema, the conditions can be differentiated under the microscope by their acanthotic or non-acanthotic appearance. Suchonwanit P, Hector CE, Bin Saif GA, McMichael AJ. doi: 10.1016/j.jdcr.2018.04.002, 12. This site needs JavaScript to work properly. Book appointments online with Optimized Health and Wellness of Hudson, FL.